Diabetes Research and Clinical Practice
Volume 88, Issue 2 , Pages 177-183 , May 2010

Increased plasma adiponectin closely associates with vascular endothelial dysfunction in type 2 diabetic patients with diabetic nephropathy

Received 11 December 2009 ,Accepted 18 January 2010.

References 

  1. Agabiti-Rosei E. From macro- to microcirculation: benefits in hypertension and diabetes. J. Hypertens. Suppl. 2008;26:S15–S19
  2. Ray A, Huisman MV, Tamsma JT, Research Writing-Group , van Asten J, Bingen BO, et al. The role of inflammation on atherosclerosis, intermediate and clinical cardiovascular endpoints in type 2 diabetes mellitus. Eur. J. Intern. Med. 2009;20:253–260
  3. Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ. J. 2009;73:608–614
  4. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 2008;93:S64–S73
  5. Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J. Cardiometab. Syndr. 2009;4:44–49
  6. Koshimura J, Fujita H, Narita T, Shimotomai T, Hosoba M, Yoshioka N, et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem. Biophys. Res. Commun. 2004;316:165–169
  7. Bakkaloglu SA, Soylemezoglu O, Buyan N, Funahashi T, Elhan AH, Peru H, et al. High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse. Pediatr. Nephrol. 2005;20:474–477
  8. Ran J, Lao G, Zhang Y, Liu W, Feng Q, Xiong X, et al. A pilot study on mechanisms of hyeradiponectinemia in two rat models with different in vivo insulin sensitivity. Chin. J. Pathophys. 2009;25:529–535
  9. Navarro-González JF, Jarque A, Muros M, Mora C, García J. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev. 2009;20:165–173
  10. Mogensen CE. Practice guidelines for chronic kidney disease. Ann. Intern. Med. 2004;140:933–934
  11. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 2002;39:257–265
  12. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 1999;340:14–22
  13. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 2002;13:134–141
  14. Zoccali C. Endothelial dysfunction in CKD: a new player in town?. Nephrol. Dial. Transplant. 2008;23:783–785
  15. Lin J, Hu FB, Curhan G. Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care. 2007;30:239–244
  16. Nishio S, Gibert Y, Bernard L, Brunet F, Triqueneaux G, Laudet V. Adiponectin and adiponectin receptor genes are coexpressed during zebrafish embryogenesis and regulated by food deprivation. Dev. Dyn. 2008;237:1682–1690
  17. Lionetti L, Mollica MP, Lombardi A, Cavaliere G, Gifuni G, Barletta A. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr. Metab. Cardiovasc. Dis. 2009;19:146–152
  18. Shimotomai T, Kakei M, Narita T, Koshimura J, Hosoba M, Kato M, et al. Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria. Ren. Fail. 2005;27:323–328
  19. Looker HC, Krakoff J, Funahashi T, Matsuzawa Y, Tanaka S, Nelson RG, et al. Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J. Clin. Endocrinol. Metab. 2004;89:4010–4017
  20. Wakabayashi S, Aso Y. Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation. Diabetes Care. 2004;27:2392–2397
  21. Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, et al. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care. 2005;28:1410–1414
  22. Schalkwijk CG, Chaturvedi N, Schram MT, Fuller JH, Stehouwer CD EURODIAB Prospective Complications Study Group. Adiponectin is inversely associated with renal function in type 1 diabetic patients. J. Clin. Endocrinol. Metab. 2006;91:129–135
  23. Kluz J, Kopec W, Jakobsche-Policht U, Adamiec R. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis. Int. Angiol. 2009;28:192–201
  24. Małyszko J, Małyszko JS, Myśliwiec M. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?. Thromb. Res. 2005;115:19–24
  25. Saito T, Saito O, Kawano T, Tamemoto H, Kusano E, Kawakami M, et al. Elevation of serum adiponectin and CD146 levels in diabetic nephropathy. Diabetes Res. Clin. Pract. 2007;78:85–92
  26. Hoseini VN, Rasouli M. Microalbuminuria correlates with the prevalence and severity of coronary artery disease in non-diabetic patients. Cardiol. J. 2009;16:142–145
  27. Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt-Rasmussen B. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet. Med. 2000;17:644–649
  28. Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, et al. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol. Dial. Transplant. 2008;23:1621–1627
  29. Lester SJ, Eleid MF, Khandheria BK, Hurst RT. Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis. Mayo Clin. Proc. 2009;84:229–233
  30. Yeboah J, Burke GL, Crouse JR, Herrington DM. Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: the Cardiovascular Health Study. Atherosclerosis. 2008;197:840–845
  31. Schlaich MP, Grassi G, Lambert GW, Straznicky N, Esler MD, Dixon J, et al. European Society of Hypertension Working Group on Obesity. Obesity-induced hypertension and target organ damage: current knowledge and future directions. J. Hypertens. 2009;27:207–211
  32. Lamon BD, Hajjar DP. Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am. J. Pathol. 2008;173:1253–1264
  33. Vionnet N, Tregouët D, Kazeem G, Gut I, Groop PH, Tarnow L, et al. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes. 2006;55:3166–3174
  34. Yoshioka K, Yoshida T, Umekawa T, Kogure A, Takakura Y, Toda H, et al. Adiponectin gene polymorphism (G276T) is not associated with incipient diabetic nephropathy in Japanese type 2 diabetic patients. Metabolism. 2004;53:1223–1226
  35. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimbürger O, Zhang Z, Hoff C, et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int. 2004;65:274–281
  36. Ma J, Möllsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S, et al. Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy. J. Diabetes Complications. 2007;21:28–33
  37. Marchlewska A, Stenvinkel P, Lindholm B, Danielsson A, Pecoits-Filho R, Lönnqvist F, et al. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney Int. 2004;66:46–50

PII: S0168-8227(10)00044-6

doi: 10.1016/j.diabres.2010.01.021

Diabetes Research and Clinical Practice
Volume 88, Issue 2 , Pages 177-183 , May 2010

Article Tools

* Image Usage & Resolution